CYP2D6 Genetic Variation and Beta-Blocker Maintenance Dose in Patients with Heart Failure

PURPOSE: This study examined whether a CYP2D6 polymorphism (CYP2D6*4) was related to beta-blocker maintenance dose in patients with heart failure. METHODS: Logistic regression modeling was utilized in a retrospective chart-review analysis of heart-failure patients (60% Male, 90% of European descent)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharm Res
Main Authors: Luzum, Jasmine A., Sweet, Kevin M., Binkley, Philip F., Schmidlen, Tara J., Jarvis, Joseph P., Christman, Michael F., Sadee, Wolfgang, Kitzmiller, Joseph P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5500390/
https://ncbi.nlm.nih.gov/pubmed/28181117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-017-2104-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados